Publications
Detailed Information
A randomized, double-blind, controlled clinical trial to evaluate the efficacy and safety of CJ-50300, a newly developed cell culture-derived smallpox vaccine, in healthy volunteers
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Jang, Hee-Chang | - |
dc.contributor.author | Kim, Choong Jong | - |
dc.contributor.author | Kim, Kye Hyoung | - |
dc.contributor.author | Lee, Kwang-Hee | - |
dc.contributor.author | Seong, Baik-Lin | - |
dc.contributor.author | Czerkinsky, Cecil | - |
dc.contributor.author | Park, Sang-Won | - |
dc.contributor.author | Kim, Nam Joong | - |
dc.contributor.author | Oh, Myoung-don | - |
dc.contributor.author | Kim, Hong-Bin | - |
dc.contributor.author | Park, Wan Beom | - |
dc.contributor.author | Saletti, Giulietta | - |
dc.contributor.author | Byun, Young-Ho | - |
dc.date.accessioned | 2012-05-25T04:28:10Z | - |
dc.date.available | 2012-05-25T04:28:10Z | - |
dc.date.issued | 2010-08-16 | - |
dc.identifier.citation | VACCINE; Vol.28 36; 5845-5849 | ko_KR |
dc.identifier.issn | 0264-410X | - |
dc.identifier.uri | https://hdl.handle.net/10371/76457 | - |
dc.description.abstract | A randomized, double-blind, controlled clinical trial was conducted to evaluate the efficacy and safety of CJ-50300, a newly developed cell culture-derived smallpox vaccine, and to determine its minimum effective dose. The overall rates of cutaneous "take" reaction and humoral and cellular immunogenicity in CJ-50300 vaccinees were 100% (123/123), 99.2%(122/123), and 90.8% (109/120). respectively, and these rates did not differ significantly between the conventional-dose and the low-dose CJ-50300 (1.0 x 10(8) and 1.0 x 10(7) plaque-forming units/mL, respectively) (P > 0.05 for each). No serious adverse reaction was observed. However, one case of possible generalized vaccinia occurred in the conventionally dosed group [ClinicalTrials.gov Identifier: NCT006072431]. (C) 2010 Elsevier Ltd. All rights reserved. | ko_KR |
dc.language.iso | en | ko_KR |
dc.publisher | ELSEVIER SCI LTD | ko_KR |
dc.subject | Smallpox vaccine | ko_KR |
dc.subject | Efficacy | ko_KR |
dc.subject | Immunity | ko_KR |
dc.title | A randomized, double-blind, controlled clinical trial to evaluate the efficacy and safety of CJ-50300, a newly developed cell culture-derived smallpox vaccine, in healthy volunteers | ko_KR |
dc.type | Article | ko_KR |
dc.contributor.AlternativeAuthor | 장희창 | - |
dc.contributor.AlternativeAuthor | 김충종 | - |
dc.contributor.AlternativeAuthor | 김계형 | - |
dc.contributor.AlternativeAuthor | 이광희 | - |
dc.contributor.AlternativeAuthor | 변영호 | - |
dc.contributor.AlternativeAuthor | 성백린 | - |
dc.contributor.AlternativeAuthor | 박완범 | - |
dc.contributor.AlternativeAuthor | 박상원 | - |
dc.contributor.AlternativeAuthor | 김홍빈 | - |
dc.contributor.AlternativeAuthor | 오명돈 | - |
dc.contributor.AlternativeAuthor | 김남중 | - |
dc.identifier.doi | 10.1016/j.vaccine.2010.06.063 | - |
dc.citation.journaltitle | VACCINE | - |
dc.description.citedreference | Kim SH, 2007, VACCINE, V25, P6287, DOI 10.1016/j.vaccine.2007.05.044 | - |
dc.description.citedreference | Beigel J, 2007, VACCINE, V25, P5745, DOI 10.1016/j.vaccine.2007.02.086 | - |
dc.description.citedreference | Rock MT, 2006, J INFECT DIS, V194, P435 | - |
dc.description.citedreference | Kim SH, 2006, J INFECT DIS, V194, P377 | - |
dc.description.citedreference | Bryant-Genevier M, 2006, VACCINE, V24, P3632, DOI 10.1016/j.vaccine.2006.01.052 | - |
dc.description.citedreference | Kim H, 2006, ANN SURG ONCOL, V13, P4 | - |
dc.description.citedreference | 2006, INVESTIGATORS BROCHU | - |
dc.description.citedreference | Kim SH, 2005, J INFECT DIS, V192, P1066 | - |
dc.description.citedreference | Artenstein AW, 2005, VACCINE, V23, P3301, DOI 10.1016/j.vaccine.2005.01.079 | - |
dc.description.citedreference | Greenberg RN, 2005, LANCET, V365, P398 | - |
dc.description.citedreference | Kennedy JS, 2004, J INFECT DIS, V190, P1286 | - |
dc.description.citedreference | Talbot TR, 2004, JAMA-J AM MED ASSOC, V292, P1205 | - |
dc.description.citedreference | Weltzin R, 2003, NAT MED, V9, P1125, DOI 10.1038/nm916 | - |
dc.description.citedreference | Fulginiti VA, 2003, CLIN INFECT DIS, V37, P241 | - |
dc.description.citedreference | Frey SE, 2003, JAMA-J AM MED ASSOC, V289, P3295, DOI 10.1001/jama.289.24.3295 | - |
dc.description.citedreference | Grabenstein JD, 2003, JAMA-J AM MED ASSOC, V289, P3278, DOI 10.1001/jama.289.24.3278 | - |
dc.description.citedreference | Talbot TR, 2003, JAMA-J AM MED ASSOC, V289, P3290, DOI 10.1001/jama.289.24.3290 | - |
dc.description.citedreference | Frey SE, 2002, NEW ENGL J MED, V346, P1265, DOI 10.1056/NEJMoa020534 | - |
dc.description.citedreference | Frey SE, 2002, NEW ENGL J MED, V346, P1275, DOI 10.1056/NEJMoa013431 | - |
dc.description.citedreference | ROTZ LD, 2001, MMWR RECOMM REP, V50, P1 | - |
dc.description.citedreference | ROTZ LD, 2001, MMWR RECOMM REP, V50, pCE1 | - |
dc.description.citedreference | FREY SE, 2000, VACCINE, V27, P1637 | - |
dc.description.citedreference | ACAM2000 SMALLPOX VA | - |
dc.description.citedreference | *EMEA CPMP, NOT GUID DEV VACC VI | - |
dc.description.tc | 1 | - |
- Appears in Collections:
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.